Cited by

• Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation.

  Wysokinski WE, Melduni RM, Ammash NM, Vlazny DT, Konik E, Saadiq RA, Gosk-Bierska I, Slusser J, Grill D, McBane RD. Wysokinski WE, et al. CJC Open. 2020 Nov 13;3(3):318-326. doi: 10.1016/j.cjco.2020.10.018. eCollection 2021 Mar. CJC Open. 2020. PMID: 33778448 Free PMC article.
• Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism.

  Hald EM, Løchen ML, Hveem K, Cushman M, Brækkan SK, Hansen JB. Hald EM, et al. Res Pract Thromb Haemost. 2025 May 8;9(4):102880. doi: 10.1016/j.rpth.2025.102880. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40687386 Free PMC article.
• Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.

  Cimmino G, Loffredo FS, Gallinoro E, Prozzo D, Fabiani D, Cante L, Salerno G, Cappelli Bigazzi M, Golino P. Cimmino G, et al. Medicina (Kaunas). 2021 May 3;57(5):444. doi: 10.3390/medicina57050444. Medicina (Kaunas). 2021. PMID: 34063719 Free PMC article. Review.
• Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.

  Go AS, Al-Khatib SM, Desvigne-Nickens P, Bansal N, Bushnell CD, Fang MC, Freeman JV, Gage BF, Hanke T, Hylek EM, Lopes RD, Noseworthy PA, Reddy VY, Singer DE, Thomas KL, True Hills M, Turakhia MP, Zieman SJ, Cooper LS, Benjamin EJ. Go AS, et al. Stroke. 2023 Mar;54(3):e75-e85. doi: 10.1161/STROKEAHA.121.038273. Epub 2023 Feb 27. Stroke. 2023. PMID: 36848427 Free PMC article. Review.
• [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

  Leithäuser B, Kasch F, Broemel T, Park JW. Leithäuser B, et al. Herz. 2010 Dec;35(8):576-80. doi: 10.1007/s00059-010-3384-5. Herz. 2010. PMID: 20927501 German.